Freedom Capital Markets maintains Inspire Medical Systems at Buy, lowers price target to $93 from $97
Freedom Capital Markets kept Inspire Medical Systems' rating at Buy but reduced its price target to $93 from $97, a 4.1% decrease. This implies a 53.6% upside from the Nov 12 close of $60.54. Recent analyst price targets for the company range from $60 to $76.

